Late-Breaking Phase 3 Data at AAD 2023 Show Oral Investigational Medicine Deuruxolitinib Significantly Improved Scalp Hair Regrowth in Alopecia Areata

MUMBAI, India and PRINCETON, N.J. , March 18, 2023 /PRNewswire/ — Concert Pharmaceuticals (“Concert”), a company recently acquired by Sun Pharmaceutical Industries Limited (including its subsidiaries and/or associated companies, “Sun Pharma”), today announced the presentation of data…